Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Indivior Pharmaceuticals Inc. (INDV) vs Liquidia Corporation (LQDA)

Indivior Pharmaceuticals Inc. and Liquidia Corporation are both Drug Manufacturers Specialty & Generic companies. Liquidia Corporation is the larger, with a market value of $6.4B against $4.3B — 1.5× the size. Indivior Pharmaceuticals Inc. trades at the lower P/E: 12.4× against 43.6×. Liquidia Corporation grew revenue faster over the last twelve months: 2,233.7% against 13.5%. Liquidia Corporation has the higher net margin (30.7% vs 26.8%) and the lower return on invested capital (121.1% vs 460.5%). Across the 19 metrics below, Liquidia Corporation leads on 11 and Indivior Pharmaceuticals Inc. on 8.

Valuation

Metric INDV LQDA Drug Manufacturers Specialty & Generic median
P/E 12.40 43.59 20.14
P/S 3.20 13.49 2.25
P/B n/m 31.17 1.90
Price to free cash flow n/m 40.36 16.54
EV/EBITDA 10.43 35.09 12.29
EV/Sales 3.42 13.25 2.56
Earnings yield 8.07% 2.29% (2.99%)
Free cash flow yield (2.65%) 2.48% 0.00%

Profitability

Metric INDV LQDA Drug Manufacturers Specialty & Generic median
Gross margin 81.97% 92.54% 53.94%
Operating margin 31.56% 37.39% 0.00%
Net margin 26.75% 30.74% 0.00%
Free cash flow margin (8.34%) 33.42% 0.00%
Return on equity (153.12%) 131.82% (0.40%)
Return on assets 26.52% 35.57% (3.32%)
Return on invested capital 460.53% 121.05% 0.00%

Growth

Metric INDV LQDA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 13.47% 2,233.65% 10.01%
EPS growth (last fiscal year) 3,017.87% 51.81% —
Revenue growth, 5-year CAGR 13.88% 65.24% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INDV LQDA Drug Manufacturers Specialty & Generic median
Debt to equity (2.34) 0.90 0.05
Current ratio 0.84 2.31 2.31
Net debt to EBITDA 0.44 (0.01) 0.85

Dividend

Metric INDV LQDA Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio — 0.00 0.00

Size

Metric INDV LQDA Drug Manufacturers Specialty & Generic median
Market cap 4.25b 6.36b 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack